Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of bipolar 1 disorder, currently experiencing a mixed or manic episode or stable~* Two or more bipolar mood episodes in the last 2 years excluding current episode~* Negative pregnancy test~Exclusion Criteria:~* History of \> than 4 mood episodes a year during the last two years~* patients experiencing a depressive episode~* History of antisocial or borderline personality illness~* Has unstable or serious general medical illness~* Has received medications disallowed by study criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 001 (Type: EXPERIMENTAL): Risperdal Consta 12.5 25 37.5 or 50mg intramuscular (IM) injection every 2 weeks
- 002 (Type: PLACEBO_COMPARATOR): Placebo Matching placebo intramuscular (IM) injection every 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).